PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21113004-12	2010	Our results indicate that NTS1 seems essential for d-amphetamine and dizocilpine disruption of PPI.	Dextroamphetamine	51-64	neurotensin	Mus musculus	26-30	
20193696-5	2010	Systemic administration of d-amphetamine (4 mg/kg, ip) increased glutamate release by 500% in WT mice, as compared to 300% in NTS2(-/-) mice, and 250% in NTS1(-/-) mice.	Dextroamphetamine	27-40	neurotensin	Mus musculus	154-158	
20193696-7	2010	Therefore, NTS1 and NTS2 modulate basal release of D-serine and glutamate, and also d-amphetamine-induced GABA and glutamate release in striatum.	Dextroamphetamine	84-97	neurotensin	Mus musculus	11-15	
20211191-8	2010	NTS1(-/-) mice showed higher locomotor activity and exaggerated dopamine release in response to d-amphetamine.	Dextroamphetamine	96-109	neurotensin	Mus musculus	0-4	
16632196-4	2006	AMP-elicited Fos expression was significantly attenuated in the medial striatum of NT null mutant mice, but was unaffected in other striatal territories.	Dextroamphetamine	0-3	neurotensin	Mus musculus	83-85	
16632196-7	2006	These data suggest that NT is required for the full activation by AMP of medial striatal neurons.	Dextroamphetamine	66-69	neurotensin	Mus musculus	24-26